Prahalad is an NIH-funded physician scientist whose research focuses on determining who develops juvenile arthritis and why. Currently, nearly 300,000 children in the United States are living with juvenile arthritis.
Prahalad assumes the position held by Larry Vogler, MD, who is stepping down as division chief after 17 years. Vogler will continue to provide patient care and teach at Emory University School of Medicine.
"We are very grateful to Dr. Vogler for dedicating his time and passion to building an outstanding pediatric rheumatology program," says Barbara Stoll, MD, the George W. Brumley, Jr. Professor and chair of the Department of Pediatrics, president and CEO of the Emory-Children's Center and chief academic officer of Children's Healthcare of Atlanta. "Acknowledged to be a master clinician, Dr. Vogler provided outstanding care to children with rheumatic disorders for many years as the only pediatric rheumatologist at Emory. He has recruited excellent clinical and research faculty to expand the division."
Prahalad was recruited to Emory in 2009 and holds dual appointments in the Departments of Pediatrics and Human Genetics. He is an oustanding NIH-funded physician scientist whose research focuses on determining who develops juvenile arthritis and why. Prahalad also serves as medical director of infusion and laboratory services at the Emory-Children's Center and is an attending physician at Children's Healthcare of Atlanta. In addition, Prahalad serves the pediatric rheumatology community by his leadership roles in the American College of Rheumatology and the Childhood Arthritis and Rheumatology Research Alliance.
"Dr. Prahalad is well poised to elevate our Division of Pediatric Rheumatology to national preeminence, with his breadth of experience and his commitment to both research and patient care," says Stoll.